Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 2/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.51 |
| ▸ | BMP1 | P13497 | 1/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.43 |
| ▸ | GNPAT | O15228 | 1/20 | 0.42 |
| ▸ | ECE1 | P42892 | 2/20 | 0.42 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5971672 | 1.00 | ALOX15 (0.53) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL31514361 | 0.97 | ALOX15 (0.50) | ALOX15BLMPMP22KMT2ADPP4 | |
| Acetic Acid SCHEMBL30311271 | 0.95 | DPP4 (0.51) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL5971152 | 0.92 | KMT2A (0.55) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL20495523 | 0.92 | KMT2A (0.55) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL5971163 | 0.92 | KMT2A (0.55) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL1674757 | 0.90 | DPP4 (0.54) | DPP4DPP8DPP9BMP1ENPEP | |
| SCHEMBL29517676 | 0.90 | DPP4 (0.54) | DPP4DPP8DPP9BMP1ENPEP | |
| SCHEMBL1674753 | 0.90 | DPP4 (0.54) | DPP4DPP8DPP9BMP1ENPEP | |
| SCHEMBL29630381 | 0.90 | BMP1 (0.49) | ALOX15BLMPMP22KMT2ADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263437-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2025-08-21 | — | — | US | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| EP-4276105-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) | 2023-11-15 | — | — | EP | claimed |
| US-20230295233-A1 | POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2023-09-21 | — | — | US | claimed |
| CN-116133673-A | Polypeptide for repairing mucous membrane injury or skin wound and application thereof | 四川好医生攀西药业有限责任公司 | 2023-05-16 | — | — | CN | claimed |
| EP-4177259-A1 | POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF | Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) | 2023-05-10 | — | — | EP | claimed |
| US-20230084521-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2023-03-16 | — | — | US | claimed |
| CN-114805489-A | Polypeptide for repairing skin injury or mucous membrane injury and application thereof | 四川好医生攀西药业有限责任公司 | 2022-07-29 | — | — | CN | claimed |
| WO-2022148289-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | 四川好医生攀西药业有限责任公司 | 2022-07-14 | — | — | WO | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
| EP-2661266-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | Elcelyx Therapeutics, Inc. (US) | 2013-11-13 | — | — | EP | claimed |
| WO-2012094636-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-07-12 | — | — | WO | claimed |
| US-20250346890-A1 | LEUKEMIA TREATMENT | DEUTSCHES KREBSFORSCH (DE) | 2025-11-13 | — | — | US | disclosed |
| US-20250312361-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | EPALEX CORP (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250263437-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2025-08-21 | — | — | US | disclosed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2004055048-A2 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2004-07-01 | — | — | WO | disclosed |
| US-4975418-A | Therapeutically active compositions of pseudo-peptide of glutamyl-aspartic acid | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (CNRS) (FR) | 1990-12-04 | — | — | US | disclosed |
| EP-0266385-A1 | THERAPEUTICALLY ACTIVE PSEUDO-PEPTIDE OF GLUTAMYL-ASPARTIC ACID | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1988-05-11 | — | — | EP | disclosed |
| WO-1987006931-A1 | THERAPEUTICALLY ACTIVE PSEUDO-PEPTIDE OF GLUTAMYL-ASPARTIC ACID | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 1987-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312361-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | FOS, FOSB, PFAS | ALOX15 946/4885BLM 1356/4885PMP22 91/4885 |
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | ALOX15 946/4885BLM 1356/4885PMP22 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.